About 396,000 results
https://finance.yahoo.com/quote/SAGE/Morgan Stanley Gets Wise On Sage Therapeutics, Initiates With A Buy. SAGE
Therapeutics Inc (NASDAQ: SAGE ) has had a laudable 109-percent run in
recent months after meeting primary endpoints in multiple trials and securing
regulatory approvals. It found further reason ... ACCESSWIRE•25 days ago ...
https://www.nasdaq.com/symbol/sageStock quote for Sage Therapeutics, Inc. Common Stock Common Stock (SAGE)
with real-time last sale and extended hours stock prices, company news, charts,
and research at Nasdaq.
www.nasdaq.com/markets/ipos/.../sage-therapeutics-inc-925099-75748Proposed Symbol, SAGE. Exchange, NASDAQ. Share Price, $18.00. Shares
Offered, 5,000,000. Offer Amount, $90,000,000.00. Total Expenses,
$2,240,000.00. Shares Over Alloted, 0. Shareholder Shares Offered, --. Shares
Outstanding, 24,961,926. Lockup Period (days), 180. Lockup Expiration, 1/14/
2015. Quiet Period ...
https://www.nasdaq.com/symbol/sage/after-hoursSage Therapeutics, Inc. (SAGE) After Hours Trading - View free After Hours stock
trades at NASDAQ.com.
Real time Sage Therapeutics (SAGE) stock price quote, stock graph, news &
Rating: 3 - 50 votes
https://www.thestreet.com/quote/SAGE.htmlView detailed financial information, real-time news, videos, quotes and analysis
on SAGE Therapeutics Inc. (NASDAQ:SAGE). Explore commentary on SAGE
Therapeutics Inc. and hear what the experts at TheStreet are saying about SAGE.
https://www.marketwatch.com/investing/stock/sageSage Therapeutics Inc. stock price, stock quotes and financial overviews from
https://stocktwits.com/symbol/SAGEReal-time trade and investing ideas on Sage Therapeutics SAGE from the largest
community of traders and investors.
Thinking about adding SAGE Therapeutics (NASDAQ:SAGE) stock to your your
Rating: 3.6 - 525 votes
portfolio? View SAGE's stock price, price target, analyst ratings, earnings history,
financials, history, insider trades, news headlines and SEC filings in real-time at
https://www.benzinga.com/.../morgan-stanley-gets-wise-on-sage-therapeutics- initiatesFeb 26, 2018 ... SAGE Therapeutics Inc (NASDAQ: SAGE) has had a laudable 109-percent run in
recent months after meeting primary endpoints in multiple trials and securing ...